This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
9, 2024 — A physician-scientist from Massachusetts researching whether chemicals naturally occurring in foods could help treat heartdisease, a genetics expert from Pennsylvania exploring the molecular mechanisms of lipid metabolism and. DALLAS, Jan.
milla1cf Tue, 01/09/2024 - 11:32 January 9, 2024 — Cleerly , the company working to create a new standard of care for the diagnosis of heartdisease, announced the launch of Cleerly ISCHEMIA , which recently received U.S. Food and Drug Administration (FDA) 510(k) medical device clearance.
The American Heart Association's annual report on heartdisease and stroke statistics for 2024 sheds new light on the impact and level of public education surrounding the impact of heartdisease and stroke in the US and abroad.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heartdisease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
tim.hodson Thu, 08/15/2024 - 10:32 Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heartdisease risk for many Americans, according to a study led by UT Southwestern Medical Center researchers and published in JAMA Cardiology. Ann Marie Navar, M.D., Eric Peterson, M.D.,
milla1cf Mon, 01/15/2024 - 12:47 January 15, 2024 — Larry Goldstein , M.D. chair of the University of Kentucky Department of Neurology , has been selected to serve as co-chair of The Kentucky HeartDisease and Stroke Prevention (KHDSP) Task Force representing stroke systems of care across the state. Photo by Shaun Ring.
History of the Congenital Heart Futures Act First passed into law in 2010, the bipartisan Congenital Heart Futures Act was groundbreaking legislation authorizing research and data collection specific to Congenital HeartDisease. Raising awareness of CHD through the lifespan.
milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heartdisease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.
June 4, 2024 — The countdown has begun ahead of the American Society of Echocardiography 35th Annual ASE Scientific Sessions, June 14-26, at the Oregon Convention Center in Portland, OR. The Program Chair for ASE 2024 is Federico Asch, MD, FASE, MedStar Health and Georgetown University (Wash.,
BackgroundRisk prediction models for depression in patients with coronary heartdisease are increasingly being developed. However, the quality and applicability of these models in clinical practice remain uncertain.ObjectiveTo systematically evaluate depression risk prediction models in patients with coronary heartdisease (CHD).MethodsDatabases
85-year-old patient with ischemic heartdisease, who underwent cardiac MRI at 3 T. Short-axis image from standard cine balanced SSFP breath-hold sequence. Short-axis image from free-breathing accelerated cine sequence with deep-learning reconstruction. Images show normal appearance of left ventricular myocardium.
milla1cf Tue, 06/11/2024 - 18:18 June 11, 2024 — Using an advanced artificial intelligence tool, researchers at the Icahn School of Medicine at Mount Sinai have identified rare coding variants in 17 genes that shed light on the molecular basis of coronary artery disease ( CAD ), the leading cause of morbidity and mortality worldwide.
A projected rise in heartdisease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 christine.book Tue, 06/18/2024 - 11:22 June 18, 2024 — At least 6 in 10 adults in an older, more diverse U.S. to 61% of the U.S. population.
milla1cf Mon, 01/29/2024 - 11:00 January 29, 2024 — The Society of Thoracic Surgeons has released late-breaking research scheduled for presentation at the 2024 Annual Meeting taking place January 27 - 29 in San Antonio.
The following are key points to remember from a 2024 report of the American College of Cardiology/American Heart Association (ACC/AHA) on performance and quality measures for adults with valvular and structural heartdisease.
2024 Jan 14. 8 The relationship between genetic liver fat and coronary heartdisease is explained by apoB-containing lipoproteins. 2024 Jan;388:117397. Obesity (Silver Spring). 7 Aetiology of Type 2 diabetes in people with a 'normal' body mass index: testing the personal fat threshold hypothesis. Clin Sci (Lond).
Nature Reviews Cardiology, Published online: 18 March 2024; doi:10.1038/s41569-024-01001-5 Non-coding RNAs are implicated in the pathophysiology of ischaemic heartdisease and heart failure.
Here is our curated list of the top interventional cardiology conferences and courses scheduled for 2024. Additionally, be sure to review the main general cardiology conferences listed in our Top 10 Cardiology Conferences for 2024. Noncoronary topics like structural heartdisease and vascular medicine are also addressed.
Video Pitfalls in Adult Congenital HeartDisease for the Aortic Surgeon kchalko Sun, 12/01/2024 - 13:53 STS President Dr. Jennifer Romano presented at the 2024 STS and Asian Society for Cardiovascular and Thoracic Surgery Aortic Summit in Tokyo (November 16, 2024) on adults with congenital heartdisease.
On March 08, 2024, the FDA approved semaglutide 2.4 mg (Wegovy) to reduce cardiovascular risk in adults with obesity or overweight and heartdisease based on the SELECT trial.
The prevalence of congenital heartdisease (CHD) is higher among those who live at higher altitudes, and more prevalent among females, according to a new study presented at ACC Latin America 2024.
DALLAS, JANUARY 16, 2024 — A patient’s oral health can be an indicator of overall health and well-being. Research shows that chronic gum inflammation may be associated with other chronic diseases including coronary artery disease and diabetes.[1]
The global prevalence of congenital heartdisease is higher among women who live at high altitudes, according to a new study presented at ACC Latin America 2024 in Punta Cana, Dominican Republic.
More than heartdisease or cancer, dementia is the primary concern for many of the patients I see. Heartdisease and cancer attack your body, but dementia attacks your mind and identity. If preventing heartdisease is a priority, then high fitness levels should also be a priority. Alzheimers Dement.
The conference theme is “Goldilocks: Toward the Optimal Mitral Valve,” and the organizers aim to bring together distinguished experts from around the world to share their knowledge and engage in academic discussions on the latest trends in treatments related to aortic valve disease. Details coming soon!
Getty Images milla1cf Tue, 03/19/2024 - 19:09 March 19, 2024 — The American College of Cardiology ( ACC ) has selected 50 learners for its 2024 – 2025 Clinical Trials Research (CTR) program , of whom 28 structural heart cardiologists and surgeons will participate in the CTR’s new Project REACH.
== Review of ECG Rhythms — MIS-C Case Report ( 9/5 /2024 ): == What follows below are my first impressions of the ECG rhythms sent to me from the Case Report by Dimah Jarmakani et al — of a 12-year old boy with MIS-C ( M ultisystem I nflammatory S yndrome in C hildren ). RED arrows show what looks to be sinus P waves that are HUGE !!!!
Nature Reviews Cardiology, Published online: 14 November 2024; doi:10.1038/s41569-024-01099-7 Debate exists regarding the best terminology for common presentations of heartdiseases caused by epicardial and/or microvascular coronary artery disease with or without myocardial ischaemia.
Journal of the American Heart Association, Volume 13, Issue 2 , January 16, 2024. BackgroundIdentification of children with latent rheumatic heartdisease (RHD) by echocardiography, before onset of symptoms, provides an opportunity to initiate secondary prophylaxis and prevent disease progression.
The ACC 2024 meeting is now complete, after over 17,000 cardiology professionals converged in Atlanta to witness cardiovascular medicine evolve in front of their eyes. The post Cardiac Wire’s Top 8 Takeaways from ACC 2024 appeared first on Cardiac Wire.
Advancements in medical technology have revolutionized the diagnosis and treatment of heartdiseases, which pose critical chronic conditions that, if left unattended, can have fatal consequences. These algorithms, trained on large datasets, recognize patterns and features associated with heartdiseases.
mtaschetta-millane Thu, 07/11/2024 - 10:53 July 11, 2024 — Heart Test Laboratories, Inc. AI-ECG is set to change the detection of heartdisease and this latest patent further bolsters value to HeartSciences and our stakeholders.” GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.
milla1cf Thu, 04/04/2024 - 12:16 April 4, 2024 — Viz.ai , a leader in AI-powered disease detection and intelligent care coordination, announced new clinical data supporting advancements in cardiology care. The Viz HCM module is the first and only AI algorithm cleared by the FDA for HCM. “At
Getty Images milla1cf Wed, 06/05/2024 - 20:33 June 5, 2024 — Edwards Lifesciences announced it has entered into a definitive agreement to sell its Critical Care product group to BD (Becton, Dickinson and Company), in an all-cash transaction valued at $4.2 Other terms of the agreement were not disclosed.
June 27, 2024 — The countdown has begun for the Society of Cardiovascular Computed Tomography (SCCT) 19th Annual Scientific Meeting, SCCT24, “At the heart of it,” to be held July 18-21, in Washington, DC. for all attendees. 3:00 p.m. . - 5:00 p.m., a general session on “Cardiac CT in clinical trials” will be featured.
an interventional cardiologist and structural heartdisease expert at Henry Ford Health. “We We are looking forward to treating patients who have no other options for mitral stenosis diseased valves.” Patients with severely calcified mitral stenosis are often not candidates for conventional open-heart surgery,” said Dr.
Nature Reviews Cardiology, Published online: 19 July 2024; doi:10.1038/s41569-024-01063-5 Contraction of the heart is driven by cyclical interactions between myosin and actin filaments driven by ATP hydrolysis.
A version of the MESA heartdisease risk score that did not include race predicted heartdisease risk just as well as the version that includes race, according to a preliminary study presented at the American Heart Association's Scientific Sessions 2024 held Nov. 16–18, 2024, in Chicago.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content